Osmond Matthew J, Korthals Elizabeth, Zimmermann Coy J, Roth Eric J, Marr David W M, Neeves Keith B
Department of Bioengineering, University of Colorado Denver, Anschutz Medical Campus, Aurora, Colorado 80045, United States.
Department of Chemical and Biological Engineering, Colorado School of Mines, Golden, Colorado 80401, United States.
ACS Omega. 2023 Mar 16;8(12):11614-11622. doi: 10.1021/acsomega.3c00886. eCollection 2023 Mar 28.
Inflammatory bowel disease (IBD) is mediated by an overexpression of tumor necrosis factor-α (TNF) by mononuclear cells in the intestinal mucosa. Intravenous delivery of neutralizing anti-TNF antibodies can cause systemic immunosuppression, and up to one-third of people are non-responsive to treatment. Oral delivery of anti-TNF could reduce adverse effects; however, it is hampered by antibody degradation in the harsh gut environment during transit and poor bioavailability. To overcome these shortcomings, we demonstrate magnetically powered hydrogel particles that roll along mucosal surfaces, provide protection from degradation, and sustain the local release of anti-TNF. Iron oxide particles are embedded into a cross-linked chitosan hydrogel and sieved to produce 100-200 μm particles called milliwheels (m-wheels). Once loaded with anti-TNF, these m-wheels release 10 to 80% of their payload over 1 week at a rate that depends on the cross-linking density and pH. A rotating magnetic field induces a torque on the m-wheels that results in rolling velocities greater than 500 μm/s on glass and mucus-secreting cells. The permeability of the TNF-challenged gut epithelial cell monolayers was rescued in the presence of anti-TNF carrying m-wheels, which both neutralized the TNF and created an impermeable patch over leaky cell junctions. With the ability to translate over mucosal surfaces at high speed, provide sustained release directly to the inflamed epithelium, and provide barrier rescue, m-wheels demonstrate a potential strategy to deliver therapeutic proteins for the treatment of IBD.
炎症性肠病(IBD)由肠道黏膜中的单核细胞过度表达肿瘤坏死因子-α(TNF)介导。静脉注射中和性抗TNF抗体可导致全身免疫抑制,高达三分之一的人对治疗无反应。口服抗TNF可减少不良反应;然而,在转运过程中,抗体在恶劣的肠道环境中降解,生物利用度差,这阻碍了口服给药。为了克服这些缺点,我们展示了一种磁驱动水凝胶颗粒,它能沿着黏膜表面滚动,提供抗降解保护,并持续局部释放抗TNF。将氧化铁颗粒嵌入交联壳聚糖水凝胶中,筛分后制成100-200μm的颗粒,称为毫轮(m轮)。一旦装载了抗TNF,这些m轮在1周内释放其10%至80%的载荷,释放速率取决于交联密度和pH值。旋转磁场在m轮上产生扭矩,导致其在玻璃和分泌黏液的细胞上的滚动速度大于500μm/s。在携带抗TNF的m轮存在的情况下,TNF刺激的肠道上皮细胞单层的通透性得到恢复,m轮既能中和TNF,又能在渗漏的细胞连接处形成一个不可渗透的补丁。m轮具有在黏膜表面高速移动、直接向炎症上皮持续释放药物以及提供屏障修复的能力,展示了一种递送治疗性蛋白质治疗IBD的潜在策略。